Kidney disease decisions — 2025

The Board granted a 100 percent rating for chronic renal disease with nephrolithiasis and hypertension from March 26, 2019, but no earlier.

The rating reduction from 50 percent to 30 percent for migraine headaches was improper, and the 50 percent disability rating is restored. The claims for service connection for broken nose with deviated septum, kidney disease stage III, loss of right kidney, and kidney cancer are remanded.

The Board remands the claims for an initial rating in excess of 30 percent for bilateral hearing loss, service connection for an acquired psychiatric disorder, and service connection for kidney disease to correct pre-decisional duty to assist errors.

The Board granted service connection for prostate cancer and type II diabetes mellitus under the PACT Act, but remanded the claim for chronic kidney disease.

The Board denied the Veteran's claim for an effective date prior to August 10, 2022, for the grant of service connection for papulosquamous lesions and remanded several other issues related to service connection, disability ratings, special monthly compensation, and TDIU.

The Board denied service connection for hypertension, prostate cancer, skin disorder, kidney disability, gastrointestinal disabilities, tongue disability, and back disability as there was no evidence of in-service exposure to herbicide agents or a nexus between the claimed conditions and military service.

The Board denied service connection for kidney cancer, rosacea, and status post excision of scrotum hidrocystoma as they are not related to the Veteran's service or in-service toxic exposure risk activities.

The veteran withdrew the appeal of the May 2021 rating decision, and the Board dismissed the appeal.

The Board granted service connection for benign neoplasm of the kidney and left lower extremity peripheral neuropathy as due to herbicide agent exposure.

The Board remands the claims for further development as it finds that a more adequate medical opinion is needed to address the Veteran's claimed conditions in relation to his service, including toxic exposure.

The Board dismissed the service connection claims for tinnitus and chronic kidney disease due to a procedural defect in the Veteran's appeal.

The Board denied service connection for diabetes, renal failure, and hypertension as the evidence did not support a finding that these conditions were related to toxic exposures during service.

The Board granted an initial rating of 10 percent for hypertension but denied service connection for chronic kidney disease.

The Board remands the claim for service connection for cause of death due to presumed exposure to herbicide agents (Agent Orange) as a VA opinion regarding the etiology of the Veteran's kidney cancer is needed.

The appeal was dismissed due to the Veteran's death during the pendency of the appeal.

The Board granted special monthly compensation based on aid and attendance, dismissed the appeals for service connection for a jaw condition and higher rating for PTSD, and remanded claims for service connection for chronic pain and kidney condition.

The appeal for service connection for chronic kidney disease, hypertension, and peripheral vascular disease of the right and left lower extremities was dismissed due to the Veteran's death.

The Board remands the issues of service connection for left and right kidney disabilities, as a new VA medical opinion is needed to address the Veteran's assertions regarding environmental hazard exposure during active service.

The Board denied service connection for kidney cancer and lung cancer, as the evidence did not support a causal or etiological relationship to any in-service disease, injury, incident, or exposure.

The appeal is dismissed due to the Veteran's death during the pendency of the appeal.